View Older Stories View More Recent Stories

Aug 20, 2014 04:03PM Motorcar Parts of America, Inc. (MPAA) to Offer 2M Shares
Aug 20, 2014 06:43AM Roth Capital Downgrades RGS Energy (RGSE) to Neutral
Aug 19, 2014 10:24AM Roth Affirms Cytori (CYTX) at Buy Following BARDA Update
Aug 15, 2014 02:04PM Daqo New Energy (DQ) Could Win with New China PV Ban; Canadian Solar (CSIQ), Trina (TSL) Others on Losing End - Roth Capital
Aug 15, 2014 07:14AM Roth Lifts PT on Plug Power (PLUG) Following Q2 Results; Highlights Key Takeaways from the Quarter
Aug 14, 2014 10:57AM Roth Remains Positive on Ligand Pharma (LNGD) Following New Licensing Agreement with Avion Pharma
Aug 14, 2014 09:45AM Roth Affirms Rexahn (RNN) at 'Buy'; Comments on Q2 Results, Pipeline Update
Aug 13, 2014 06:47AM Roth Capital Encouraged by ReneSola's (SOL) Progress, but Sustainable Profits Need to be Demonstrated
Aug 12, 2014 03:23PM Roth Keeps Concert Pharma (CNCE) at Buy; Making Good Progress with Clinical Programs
Aug 12, 2014 11:10AM Roth Capital Affirms 'Sell' Rating on Dendreon (DNDN) Following Q2 Results; Comments on Debt Issue
Aug 12, 2014 08:57AM UTStarcom (UTSI) CFO Resigns, Replacement Named
Aug 11, 2014 04:15PM Energy Focus Closes Public Offering of Common Stock
Aug 11, 2014 03:34PM Roth Capital Comments on Regeneron (REGN) After EC Approves Eylea for DME Patients
Aug 11, 2014 07:52AM Roth Capital Starts IRadimed Corp (IRMD) at Buy
Aug 8, 2014 09:16AM Roth Capital Raises Target on SolarCity (SCTY) 22.5% Following Q2 Results
Aug 8, 2014 06:44AM Roth Capital Downgrades Alexza Pharma (ALXA) to Neutral
Aug 7, 2014 12:05PM Roth Maintains Keryx (KERX) at 'Buy' Following Q2 Results; Long-Term Study Data Still Looks Good
Aug 7, 2014 09:02AM Roth Capital Upgrades PowerSecure (POWR) to Buy
Aug 6, 2014 02:10PM New CEO Whitaker is Positive for Synta Pharma (SNTA); Roth Affirms at 'Buy' Following Q2 Results
Aug 6, 2014 12:38PM Roth Raises Target on Enphase (ENPH) 50% Following Q2 Results and Outlook
Aug 6, 2014 08:15AM Energy Focus Announces Pricing of Public Offering of Common Stock
Aug 5, 2014 12:29PM Roth Capital Comments on Regeneron (REGN) Following Q2 Results; Affirms 'Buy' Rating
Aug 4, 2014 02:24PM Roth Still Positive on Ligand (LGND) Following Q2 Results, ASPIRE Phase 3 Update (AMGN)
Aug 4, 2014 08:50AM Key Takeaways from Hydrogenics' (HYGS) Q2 Report
Aug 4, 2014 07:00AM AGTC Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Aug 1, 2014 08:42AM Roth Capital Starts Sucampo Pharmaceuticals (SCMP) at Buy
Aug 1, 2014 06:38AM Roth Capital Starts Alcobra Ltd. (ADHD) at Buy
Jul 31, 2014 02:17PM Cytokinetics (CYTK) Valuation Remains Attractive Following Q2 Results - Roth
Jul 31, 2014 11:58AM Streetinsider.com's Hot Lunchtime Reads 07/31:(NQ) (TMUS) (TSLA) (AMCX) (MCUR)
Jul 31, 2014 11:03AM New CEO Encouraging, but Plenty of Problems Persist at Dendreon (DNDN) - Roth Capital
Jul 31, 2014 10:33AM Bio Blast Pharma (ORPN) IPO Opens, Trades Lower
Jul 30, 2014 02:15PM Maxwell (MXWL) Risk-Reward Favorable into Q2 Report on Recent Pullback, FY15 Bus Read Through
Jul 30, 2014 10:03AM Roth Boosts PT on Regeneron (REGN) to $399 Following ODYSSEY Phase III Data, EYLEA Approval
Jul 28, 2014 02:07PM Roth Capital Comments on Pharmacyclics (PCYC) Following Expanded IMBRUVICA Coverage; Affirms 'Buy' Rating
Jul 28, 2014 10:41AM Roth Affirms 'Buy' Rating on Stemline (STML); Comments on SL-401 News
Jul 28, 2014 09:30AM Pre-Open Stock Movers 7/28: (FDO) (XGTI) (TRLA) Higher; (ACRX) (HZNP) (Z) Lower (more...)
Jul 28, 2014 07:00AM Roth Capital Upgrades Prosensa (RNA) to Buy
Jul 25, 2014 12:33PM Roth Highlights Two Takeaways from SolarCity's (SCTY) ABS Offering; Maintains 'Buy' Rating
Jul 25, 2014 09:14AM Mines Management (MGN) Plans 4,000 Units Offering
Jul 25, 2014 08:58AM Roth Positive on Pharmacyclics (PCYC) Following CHMP Recommendation of Imbruvica
Jul 25, 2014 07:13AM Applied Genetic Technologies (AGTC) Prices 2M Common Offering at $15/Share
Jul 24, 2014 07:05PM AGTC Announces Pricing of Public Offering
Jul 24, 2014 10:43AM Notable Analyst Rating Changes 07/24: (RKUS) (UIS) (SEIC) Upgraded; (ANGI) (QCOM) (BA) Downgraded
Jul 24, 2014 06:45AM Roth Capital Starts CorMedix (CRMD) at Buy
Jul 23, 2014 01:55PM Roth Sees Significant Advantages to TG Therapeutics' (TGTX) TGR-1202 vs. Gilead's (GILD) Zydelig; Reiterates 'Focus Pick' Rating
Jul 23, 2014 08:57AM Ligand (LGND) Pressure on GSK's Promacta Data is Overreaction - Roth Capital
Jul 22, 2014 02:06PM NHLBI Trial Choice Validates Cytori (CYTX) as Top Stem Cell Player - Roth Capital
Jul 22, 2014 11:02AM Notable Analyst Rating Changes 07/22: (AGN) (RLGY) (FANG) Upgraded; (AMZN) (STI) (MTDR) Downgraded
Jul 22, 2014 10:07AM Roth Capital Comments on Ligand (LGND) Following SAGE-547 Update
Jul 22, 2014 09:12AM Roth Capital Raises PT on Galena (GALE) to $8 Following Zuplenz Licensing News
View More Recent Stories View Older Stories